JILL CARROLL

Profile

First Name

: JILL

Middle Name

:

Last Name

: CARROLL

Related Companies
Titles
Company Name
Related People
DIRECTOR
VASCULOX, INC.
KALTHLEEN L. BECKMANN, KATHLEEN L. BECKMANN, CHARLES BOLTEN, DAN BRODERICK, GEORGE CAPPS, JOHN DONOVAN, WILLIAM FRAZIER, ROBERT W. KARR, PAMELA MANNING, PAMELA T. MANNING, JOHN MCKEARN, PETER MOLDT, CAROLE L. NUECHTERLEIN, BOBBY W. SANDAGE, JR., JAMES STUTZ
DIRECTOR
TIOMA THERAPEUTICS, INC.
KALTHLEEN L. BECKMANN, KATHLEEN L. BECKMANN, CHARLES BOLTEN, DAN BRODERICK, GEORGE CAPPS, JOHN DONOVAN, WILLIAM FRAZIER, ROBERT W. KARR, PAMELA MANNING, PAMELA T. MANNING, JOHN MCKEARN, PETER MOLDT, CAROLE L. NUECHTERLEIN, BOBBY W. SANDAGE, JR., JAMES STUTZ
DIRECTOR
ARCELLX, INC.
TIBA AYNECHI, HUGO BEEKMAN, ALI BEHBAHANI, RAMI ELGHANDOUR, MICHELLE GILSON, CHRISTOPHER HEERY, DAVID HILBERT, HAN LEE, DAVID LUBNER, KAVITA PATEL, ROGER SAWHNEY, LANCE THIBAULT, OLIVIA WARE, LEWIS T. WILLIAMS, LEWIS T. RUSTY WILLIAMS, DEREK YOON
DIRECTOR
NKARTA, INC.
TIBA AYNECHI, FOUAD AZZAM, ALI BEHBAHANI, MICHAEL DYBBS, PAUL HASTINGS, MATTHEW PLUNKETT
DIRECTOR
PANDION THERAPEUTICS HOLDCO LLC
DANIEL BECKER, ALAN L. CRANE, DONALD FRAIL, CHRISTOPHER FUGLESANG, VIKAS GOYAL, RAHUL KAKKAR, MITCHELL MUTZ, CARLO RIZZUTO, NANCY STAGLIANO, JO VINEY
DIRECTOR
ODYSSEY THERAPEUTICS, INC.
CHARLES BAUM, CHARLES M. BAUM, CHUCK BAUM, M. CHARLES BAUM, SHELLEY CHU, GARY D GLICK, GARY D. GLICK, CARL GORDON, JASON HAAS, PAULINA HILL, LORENCE KIM, JEFFREY LEIDEN, NAN LI, CAROLYN NG, VALERIE ODEGARD, KSENIJA PAVLETIC, IAN SMITH, LAN F. SMITH, NIA TATSIS, TIMOTHY WALBERT
DIRECTOR
AVALYN PHARMA INC.
TIBA AYNECHI, LYN BARANOWSKI, DANIEL D. BURGESS, SOFIA IOANNIDOU, MICHAEL J. KAMDAR, JONATHAN LEFF, JONATHAN LEFF, M.D., CASSANDRA GIANNA LUCA, ROBERT MITTENDORFF, PETER MOLDT, A. BRUCE MONTGOMERY, BRUCE MONTGOMERY, M.D., NIALL O-DONNELL, KETAN PATEL, HEATHER PRESTON, NAVEED SIDDIQI, MARK W. SURBER, PH.D., RICHARD G. VINCENT
DIRECTOR
AIRNEXIS THERAPEUTICS, INC.
EVAN CAPLAN, ANNA CHEN, MARIA FARDIS, JAMES LI, COLIN WALSH
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-03-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2026-01-09 
2025-12-04
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2025-06-16 
2024-08-14
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-10-25 
2023-12-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-10-25 
2023-10-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-09-22 
2023-02-06
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2023-01-26 
2022-10-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-05-13 
2022-03-10
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2022-02-27 
2021-10-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-08-30 
2021-07-01
D/A
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2021-03-26 
2021-04-09
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2021-03-26 
2020-04-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-03-23 
2019-10-15
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-09 
2019-09-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-27 
2019-08-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-09 
2016-08-17
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-25 
2015-08-07
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-25